HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

pegylated liposomal doxorubicin

single use of pegylated liposomal doxorubicin has been reported to be safe and effective with varying treatment in patients with advanced hepatocellular carcinoma
Networked: 622 relevant articles (101 outcomes, 291 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Markman, Maurie: 12 articles (01/2014 - 11/2003)
2. Orlowski, Robert Z: 11 articles (11/2015 - 04/2005)
3. Scambia, Giovanni: 10 articles (07/2014 - 01/2006)
4. Scambia, G: 10 articles (11/2011 - 10/2003)
5. Pujade-Lauraine, Eric: 9 articles (11/2015 - 08/2006)
6. Vergote, Ignace: 9 articles (11/2015 - 07/2010)
7. Sehouli, Jalid: 9 articles (06/2014 - 01/2006)
8. Gabizon, Alberto: 9 articles (01/2014 - 01/2003)
9. Lorusso, D: 9 articles (05/2012 - 10/2003)
10. Monk, Bradley J: 8 articles (10/2012 - 01/2005)

Related Diseases

1. Ovarian Neoplasms (Ovarian Cancer)
2. Breast Neoplasms (Breast Cancer)
3. Neoplasms (Cancer)
4. Kaposi Sarcoma (Kaposi's Sarcoma)
5. Multiple Myeloma

Related Drugs and Biologics

1. 1-dodecylpyridoxal (PLD)
2. Doxorubicin (Adriamycin)
3. Platinum
4. Paclitaxel (Taxol)
5. Carboplatin (JM8)
6. Vincristine (Oncovin)
7. Dexamethasone (Maxidex)
8. trabectedin (ecteinascidin 743)
9. Cyclophosphamide (Cytoxan)
10. bortezomib (Velcade)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Highly Active Antiretroviral Therapy (HAART)
3. Radiotherapy
4. Aftercare (After-Treatment)
5. Intravenous Injections